22 July 2022: Articles
Multidrug-Resistant in a Patient with SARS-Cov-2 Pneumonia in an Intensive Care Unit in Guayaquil, Ecuador: A Case Report
Unusual clinical course
Betty J. Pazmiño Gómez A* , Jennifer P. Rodas Pazmiño B , Gabriel S. González Quinde B , Jorge F. Guevara Viejó B , Miguel J. Merejildo Amaguaña B , Édgar I. Rodas Neira C , Francisco A. Rizzo Rodríguez B , Luis E. Cagua Montaño C , Karen A. Rodas Pazmiño BDOI: 10.12659/AJCR.936498
Am J Case Rep 2022; 23:e936498
Table 3. Blood culture confirmation Klebsiella pneumoniae, NDM strain (confirmed at the INSPI Guayaquil, Ecuador). Microbiological findings.Klebsiella pneumoniae ss. Pneumonia.
| Cefotaxime | 6 mm | |
| Ciprofloxacin | 6 mm | |
| Meropenem | 12 mm | |
| Cefepime | 6 mm | |
| Ertapenem | 10 mm | |
| Colistin_MDC | ||
| Identification method | ||
| Sensitivity test | ||
| Interpretation rule | ||
| Carbapenemase | ||
| Inactivation Carbapenemes mCIM | ||
| Inactivation Carbapenemes eCIM | ||
| Synergy ABP-IMI | ||
| Synergy EDTA-IMI | ||
| Molecular biology research | ||
| bla-KPC | ||
| bla-VIM | ||
| bla-IMP | ||
| bla-NDM | ||
| bla-OXA48 | ||
| Comments | ||
| Ceftazidime | 6 mm | |
| Gentamicin | 20 mm | |
| Imipenem | 10 mm | |
| Amikacin | 19 mm | |
| Aztreonam | 12 mm | |
| 0.5 ug/Ml (I) | ||
| Manual | ||
| CIM-BMD + DD | ||
| CLSI | ||
| Positive | ||
| Positive | ||
| Positive | ||
| Negative | ||
| Positive | ||
| Yes | ||
| Negative | ||
| Negative | ||
| Negative | ||
| Positive | ||
| Negative | ||
| NDM-type carbapenemase-producing microorganism Consider use of combination therapy Please maintain vigilance of the microorganism | ||
| Antimicrobial susceptibility interpretation of blood culture confirmed at the INSPI. | ||